Sort
16,300 grants matching “fatty liver disease”
Biorepository Core
$221,916Claudio Fiocchi · Case Western Reserve University · P30 · FY2017 · DK
Phosphoglycerate mutase 5 (PGAM5) in the regulation of hepatic lipid metabolism and carcinogenesis
$221,821Andrea Noel Johnston · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2021 · GM
Phosphoglycerate mutase 5 (PGAM5) in the regulation of hepatic lipid metabolism and carcinogenesis
$221,819Andrea Noel Johnston · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2023 · GM
Phosphoglycerate mutase 5 (PGAM5) in the regulation of hepatic lipid metabolism and carcinogenesis
$221,819Andrea Noel Johnston · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2024 · GM
Phosphoglycerate mutase 5 (PGAM5) in the regulation of hepatic lipid metabolism and carcinogenesis
$221,819Andrea Noel Johnston · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2022 · GM
CACHET - Pilot Project
$221,761Gokhan M. Mutlu · University Of Chicago · P30 · FY2022 · ES
CACHET - Pilot Project
$221,761Gokhan M. Mutlu · University Of Chicago · P30 · FY2024 · ES
CACHET - Pilot Project
$221,761Gokhan M. Mutlu · University Of Chicago · P30 · FY2023 · ES
Development and validation of a novel 3D human in vitro model of nonalcoholic steatohepatitis to be used for novel therapeutic screening and research on disease mechanism.
$221,725Alice Chen · Organovo, Inc. · R44 · FY2017 · DK
Clinical Research Network in Nonalcoholic Steatohepatitis
$221,608Kris Kowdley · Swedish Medical Center, First Hill · U01 · FY2014 · DK
Bacterial DNA as a Diagnostic Biomarker of Hepatocellular Carcinoma
$221,595Amir Zarrinpar · University Of California, San Diego · R21 · FY2022 · CA
Precision Genetic RNAi Medicines to Treat Metastatic Triple-Negative Breast Cancer (TNBC)
$221,595Steven F Dowdy · University Of California, San Diego · R21 · FY2022 · CA
Identification of Muscle-Specific Biomarkers of Fatty Acid beta-Oxidation
$221,573Sean Harrison Adams · U.S. Agricultural Research Service · R01 · FY2012 · DK
Biomimetic NanoVilli Chips for Extracellular Vesicles in Hepatocellular Carcinoma
$221,408Yazhen Zhu · University Of California Los Angeles · R21 · FY2021 · CA
Lysosome-lipid droplet interactions in fatty acid metabolism
$221,271Jing Pu · University Of New Mexico Health Scis Ctr · P20 · FY2022 · GM
Involvement of CIDE-A in the development of liver steatosis
$221,250Bruce Kelder · Ohio University Athens · R15 · FY2010 · DK
Nano-Antioxidants as a Therapeutic for Preclinical Models of NAFLD
$221,186Robia G Pautler · Baylor College Of Medicine · R21 · FY2013 · DK
Workforce Development Core
$221,185Sarah A. Williams-Blangero · University Of Texas Rio Grande Valley · U54 · FY2025 · HG
Hepatic Stabilin-2 Mechanisms of Clearance
$221,156Edward N Harris · University Of Nebraska Lincoln · P20 · FY2017 · GM
Biorepository Core
$221,155Claudio Fiocchi · Case Western Reserve University · P30 · FY2019 · DK
Priming of liver disease by arsenic exposure
$221,131Gavin E Arteel · University Of Louisville · R21 · FY2010 · ES
Role of MicroRNA mi R-33 in Controlling Cholesterol/Lipid Homeostasis
$221,042Anders M Naar · Massachusetts General Hospital · R21 · FY2009 · DK
Core 1: Biostatistics & Bioinformatics Core
$220,932Lynne R Wilkens · University Of Hawaii At Manoa · P20 · FY2025 · CA
Bariatric Surgery Research Consortium
$220,912University Of Washington · U01 · FY2005 · DK
A novel rabbit model of cystic fibrosis
$220,875Jie Xu · University Of Michigan At Ann Arbor · R21 · FY2017 · OD